AMH and amenorrhea: In this trial, the serum AMH levels of patients decreased significantly one year post-chemotherapy, and 17.7% (14/79) of patients in the control group had amenorrhea, indicating that chemotherapy caused a certain degree of damage to the ovarian reserve function.